13n标记阿片肽的合成及生物学评价

Hideo Saji , Daisuke Tsutsumi , Yoshiaki Kiso , Satoshi Iimuma , Tsutomu Mimoto , Kenichi Akaji , Yasuhiro Magata , Hideo Nakamura , Atsuko Kita , Junji Konishi , Akira Yokoyama
{"title":"13n标记阿片肽的合成及生物学评价","authors":"Hideo Saji ,&nbsp;Daisuke Tsutsumi ,&nbsp;Yoshiaki Kiso ,&nbsp;Satoshi Iimuma ,&nbsp;Tsutomu Mimoto ,&nbsp;Kenichi Akaji ,&nbsp;Yasuhiro Magata ,&nbsp;Hideo Nakamura ,&nbsp;Atsuko Kita ,&nbsp;Junji Konishi ,&nbsp;Akira Yokoyama","doi":"10.1016/0883-2897(92)90160-Z","DOIUrl":null,"url":null,"abstract":"<div><p>The <sup>13</sup>N-labeled opioid tetrapeptide, Tyr-<span>D</span>-Met(<em>O</em>)-Phe-Gly-[<sup>13</sup>N]NH<sub>2</sub> (SD-62), was synthesized by amidation of its activated <em>p</em>-nitrophenol ester with [<sup>13</sup>N]ammonia (total synthesis time: 25 min, radiochemical yield: 48%). When injected intravenously into mice, [<sup>13</sup>N]SD-62 was taken up by the brain and this uptake was blocked by naloxone. In addition, the time course of changes in brain radioactivity paralleled that of the analgesic activity of this compound, suggesting that SD-62 underwent binding to brain opioid receptors. Thus, [<sup>13</sup>N]SD-62 appears to hold some promise for use as a radiopharmaceutical for <em>in vivo</em> studies of opioid peptide behavior, using positron emission tomography.</p></div>","PeriodicalId":14328,"journal":{"name":"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology","volume":"19 4","pages":"Pages 455-460"},"PeriodicalIF":0.0000,"publicationDate":"1992-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0883-2897(92)90160-Z","citationCount":"4","resultStr":"{\"title\":\"Synthesis and biological evaluation of a 13N-labeled opioid peptide\",\"authors\":\"Hideo Saji ,&nbsp;Daisuke Tsutsumi ,&nbsp;Yoshiaki Kiso ,&nbsp;Satoshi Iimuma ,&nbsp;Tsutomu Mimoto ,&nbsp;Kenichi Akaji ,&nbsp;Yasuhiro Magata ,&nbsp;Hideo Nakamura ,&nbsp;Atsuko Kita ,&nbsp;Junji Konishi ,&nbsp;Akira Yokoyama\",\"doi\":\"10.1016/0883-2897(92)90160-Z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The <sup>13</sup>N-labeled opioid tetrapeptide, Tyr-<span>D</span>-Met(<em>O</em>)-Phe-Gly-[<sup>13</sup>N]NH<sub>2</sub> (SD-62), was synthesized by amidation of its activated <em>p</em>-nitrophenol ester with [<sup>13</sup>N]ammonia (total synthesis time: 25 min, radiochemical yield: 48%). When injected intravenously into mice, [<sup>13</sup>N]SD-62 was taken up by the brain and this uptake was blocked by naloxone. In addition, the time course of changes in brain radioactivity paralleled that of the analgesic activity of this compound, suggesting that SD-62 underwent binding to brain opioid receptors. Thus, [<sup>13</sup>N]SD-62 appears to hold some promise for use as a radiopharmaceutical for <em>in vivo</em> studies of opioid peptide behavior, using positron emission tomography.</p></div>\",\"PeriodicalId\":14328,\"journal\":{\"name\":\"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology\",\"volume\":\"19 4\",\"pages\":\"Pages 455-460\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0883-2897(92)90160-Z\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/088328979290160Z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/088328979290160Z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

13N标记的阿片四肽,Tyr-D-Met(O)- ph - gly -[13N]NH2 (SD-62),由其活化的对硝基酚酯与[13N]氨酰胺化合成,总合成时间为25 min,放射化学产率为48%。当静脉注射到小鼠体内时,[13N]SD-62被大脑摄取,这种摄取被纳洛酮阻断。此外,脑放射性变化的时间过程与该化合物的镇痛活性变化相似,表明SD-62与脑阿片受体结合。因此,[13N]SD-62似乎有望作为一种放射性药物,利用正电子发射断层扫描技术在体内研究阿片肽的行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Synthesis and biological evaluation of a 13N-labeled opioid peptide

The 13N-labeled opioid tetrapeptide, Tyr-D-Met(O)-Phe-Gly-[13N]NH2 (SD-62), was synthesized by amidation of its activated p-nitrophenol ester with [13N]ammonia (total synthesis time: 25 min, radiochemical yield: 48%). When injected intravenously into mice, [13N]SD-62 was taken up by the brain and this uptake was blocked by naloxone. In addition, the time course of changes in brain radioactivity paralleled that of the analgesic activity of this compound, suggesting that SD-62 underwent binding to brain opioid receptors. Thus, [13N]SD-62 appears to hold some promise for use as a radiopharmaceutical for in vivo studies of opioid peptide behavior, using positron emission tomography.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信